Kezar Life Sciences, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kezar Life Sciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Kezar Life Sciences, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $762K, a 17.4% increase year-over-year.
  • Kezar Life Sciences, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $2.9M, a 42.5% increase year-over-year.
  • Kezar Life Sciences, Inc. annual Operating Lease, Payments for 2023 was $2.57M, a 149% increase from 2022.
  • Kezar Life Sciences, Inc. annual Operating Lease, Payments for 2022 was $1.03M, a 0.96% decline from 2021.
  • Kezar Life Sciences, Inc. annual Operating Lease, Payments for 2021 was $1.04M, a 15.8% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.57M +$1.53M +149% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $1.03M -$10K -0.96% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $1.04M +$142K +15.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $900K +$126K +16.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 $774K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.